Provided by Tiger Trade Technology Pte. Ltd.

TEMA ONCOLOGY ETF

44.42
-0.1739-0.39%
Volume:15.33K
Turnover:678.14K
Market Cap:214.99M
PE:- -
High:44.71
Open:44.71
Low:43.60
Close:44.59
52wk High:47.00
52wk Low:26.29
Shares:4.84M
Float Shares:4.84M
Volume Ratio:0.60
T/O Rate:0.32%
Dividend:0.02
Dividend Rate:0.04%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Legend Biotech Announces Annual General Meeting

Reuters
·
Aug 19

Eli Lilly and Co Stock (LLY) Moved Up by 3.19% on Aug 18: What Signal Does It Send?

TradingKey
·
Aug 19

Eli Lilly (LLY) Stock Looks Undervalued Relative To Fair Value

Simply Wall St.
·
Aug 19

Eli Lilly Pays $10 Million Upfront to AlzeCure Under Alzstatin Deal

MT Newswires Live
·
Aug 18

How Legend Biotech’s Q2 Profitability Jump and Interim CEO Shift Will Impact Legend Biotech (LEGN) Investors

Simply Wall St.
·
Aug 18

Swiss Stocks Flat in Early Trading

Dow Jones
·
Aug 18

Sector Update: Healthcare

MT Newswires Live
·
Aug 18

Top Midday Gainers

MT Newswires Live
·
Aug 18

Eli Lilly Canada: Disagrees with Characterizations in Canada Revenue Agency’s Application; Will Respond Formally Through Court Process in Due Course

THOMSON REUTERS
·
Aug 17

Eli Lilly Canada: Continues to Take Action to Address Promotion and Sale of Unapproved and Illegal Retatrutide Products in Canada

THOMSON REUTERS
·
Aug 17

PRESS Digest-Canada - August 17

Reuters
·
Aug 17

Leal Therapeutics: Raises $30M in Series a Extension Financing, Adds Eli Lilly as New Investor

THOMSON REUTERS
·
Aug 17

Eli Lily Initiates New Phase Iii Clinical Trials for Adult Depression Treatment Brenipatide in China - Notice

THOMSON REUTERS
·
Aug 17

Eli Lily Initiates New Phase III Clinical Trials for Brenipatide in China

Reuters
·
Aug 17

The Mediterranean Diet is the Best One Out There. Here's Why Americans Struggle with It.

Dow Jones
·
Aug 17

Eli Lilly Launches New Phase III Trial in China for Its Once-Daily Depression Candidate

Stock News
·
Aug 17

Top Premarket Gainers

MT Newswires Live
·
Aug 17

OmniAb Signs Global Ion Channel Collaboration Deal with Eli Lilly, Eyes up to $370 Million in Milestones

Reuters
·
Aug 17

Has Cogent Biosciences (COGT) Run Too Far After Wider Losses?

Simply Wall St.
·
Aug 17

Why Cogent Biosciences (COGT) Is Down 10.5% After Reporting Wider First-Half 2026 Losses – And What's Next

Simply Wall St.
·
Aug 16